2012 Annual Suncoast Parkinson Symposium at Sarasota Memorial’s Institute for Advanced Medicine

Posted by admin in Oxford Book Of Medicine

2012 Annual Suncoast Parkinson Symposium at Sarasota Memorial’s Institute for Advanced Medicine
Occasion on 2012-02-04 08:00:00
2012 ANNUAL SUNCOAST PARKINSON Disease SYMPOSIUM&quotAdvances in the Treatment of Parkinson Illness&quot

Presented by Neuro Challenge Foundation & Sarasota Memorial Wellness Care Method

A neighborhood training event for sufferers, caregivers

and healthcare companies.

Final year's occasion was the most broadly attended in the nation.

Register now to guarantee your seat.

Saturday, February 4, 2012

Sarasota Memorial's Institute for Advanced Medicine

(just one/4 mile west of I-75, exit 205)

Registration Continental Breakfast and Educational Video clips: 8:00 a.m.

Plan: 9:00 a.m. – 12:30 p.m.

Seating is Limited.

2012 Suncoast Parkinson Disease SymposiumInternationally Distinguished Faculty Presentations

&quotEarly Therapy Methods For Parkinson Illness

& Condition Modification Opportunities&quot

Moussa B. H. Youdim, PhD

Professor Emeritus, Director, Eve Topf Center, a National Parkinson Foundation Center of Excellence for Neurodegenerative Illnesses Research and Teaching at Technion Israel Institute, Haifa, Israel

Distinguished Professor, Planet Central Univerity, Yonsei University, Seoul, Korea, Distinguished Chair Professor, PolyU and Hong Kong University, China. Over 500 publications in peer-reviewed journals.

Dr. Youdim is the winner of the Daily life Sciences 2010 EMET Prize for Brain Sciences. This prize was awarded to Professor Youdim for his achievements in the area of neurological research. The EMET Prize is an annual one particular million dollar award sponsored by the A.M.N. Foundation for the Advancement of Science, Art and Culture in Israel in cooperation with the Prime Minister of Israel.

&quotExamining Motor Factors of Parkinson's Condition&quot

Cynthia Fox, PhD, CCC-SLP

Co-Founder, LSVT Global, Study Associate at the National Center for Voice and Speech in Denver, CO Study Lecturer in the Department of Neurology at the University of Arizona at Tucson Dr. Fox is an professional in the underlying mechanisms of speech issues in Parkinson Disease, and the application of LSVT^®LOUD to other neurologic conditions such as stroke.

&quotFunctional Neurosurgery and Parkinson Condition&quot

James Shumacher, MD

Neurosurgeon, Sarasota Memorial Hospital

&quotThe Significance of Early Diagnosis, Therapy

and Its Effect on Extended Expression Therapy

Technique In Parkinson's Condition&quot

Dean P. Sutherland, MD, PhD

Director, Southeastern Center for Parkinson Disease, Sarasota, FL Assistant Clinical Professor, Florida State University and University of Florida Medical Director, Neuro Challenge Foundation Neurologist, Sarasota Memorial Hospital Advisor, Michael J. Fox Trial Finder Process Force

MOUSSA B.H.YOUDIM Short BIOGRAPHY

Prof. Moussa Youdim was chairman of Pharmacology from its inception in 1977

to 1994. He is now the Finkelstein Professor of Daily life Sciences and Professor of

Pharmacology at the Technion- Rappaport Loved ones Faculty of Medicine and the

Director of the Eve Topf and National Parkinson Foundation (USA) Centers of

Excellence for Neurodegenerative Ailments Investigation and Teaching at Technion.

He is nationally and internationally acknowledged for his investigation in depressive

illness , Parkinson's condition and Alzheimer's disease and drug development for

these problems and for establishing the importance of monoamine oxidase and

brain iron metabolism for brain function that can lead to cognitive impairments

in ADHD and neurodegenerative ailments.. His analysis at Oxford University

led to the discovery of the monoamine oxidase B inhibitor, l-deprenyl

(selegiline) as an anti Parkinson drug in 1975 which was accountable for

altering the prospects of treating Parkinson's illness and other

neurodegenerative disorders with drugs that would possess feasible illness

modifying (neuroprotective) activity. His research at the Technion has led to the

improvement of the 2nd generation of monoamine oxidase inhibitor antiParkinson drug,

Rasagiline (Azilect, FDA approved) considered the initial

neuroprotective-condition modifying drug for Parkinson's Illness, in collaboration

with Teva Pharmaceutical Co. and the multifunctional neuroprotective antiAlzheimer drug currently

designated Ladostigil (Television 3326) now in Phase IIa,

with Prof. Marta Weinstock of Hebrew University. For the past 10 a long time he has

been advocating development of multimodal neuroprotective- neurorestorative

drugs with different neuron targets as treatment for neurodegenerative

disordrers., a single of whicjh is ladostigil. Far more not long ago he has created with

Prof. Mati Fridkin of Weizmann Institute novel multifunctional iron chelators

with monoamine oxidsase and cholinesterase inhibitory activity such as HLA-20,

M30, M30C and M30D for remedy of amyotrophic lateral sclerosis and

Alzheimer's condition, Lewy Body disease, CDK and diabetes. These drugs

account for much more than one hundred of Prof. Youdim's considerable number of

international patents in the area of neuropsychiatric drug development and

cardiovascular drugs. Prof. Youdim serves as a consultant for several key

international pharmaceutical companies. He serves on many National and

International scientific and grant giving committees. He has published far more

than 800 scientific content articles and edited 45 books and has been on the Editorial

Board of 43 International scientific journals. He has received several significant

awards and honours from Israel, U.S., England, Germany, Iran, Denmark,

Holland and Switzerland, including two Honoary Doctorate of Philosophy,

Honory Causa, from universities of Semmelweis University (Hungry) Qingdao

University in China. Not long ago he was created Honorary Professor and

Distinguished Chair Professor at Hong Kong and Poly U universities in Hong

Kong and Distinguished Scientific professor at Seoul Yonsei University. From

1991 by way of 1999, he was a Fogarty International Scholar-in-Residence at the

Fogarty International Center for Advanced Research in the Human Wellness Sciences

plan of the National Institute of Health in Bethesda, USA.

Sarasota Memorial Wellness Care Technique and Neuro Challenge Foundation Inc. so not endorse any commercial merchandise displayed or discussed in conjunction with this activity. The data beneath identifies planner and faculty relationships / affiliations and monetary relationships with any commercial interest that creates wellness care goods or solutions: Dean Sutherland, Planner/Faculty – Speakers Bureau: Teva Neuroscience, Glaxo-Smithkline, Consultant: GE Healthcare, Medtronic Cynthia Fox, PhD – Faculty, Commercial interest: LSVT Worldwide Moussa B. H. Youdim, Faculty, Commercial interest: Technion, Grant/Investigation Help: Teva Neuroscience

at
5880 Rand Blvd
Sarasota, United States